Drug
AP Sa02
AP Sa02: highest development phase Phase 1/2, developed by Armata Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Armata Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| AP-SA02 NCT05184764 | Phase 1/2 | Bacteremia |
Latest
No recent events.
Follow AP Sa02 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.